What You Should Know:
– Genomics plc, a leader in polygenic risk score (PRS) technology, and pharmaceutical giant GSK inks a new collaboration to explore the potential of PRS for optimizing clinical trial design.
– The…
Continue Reading
What You Should Know:
– G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development company, announced a global licensing agreement (excluding the Asia-Pacific region)…
Continue Reading
Welcome to our new episode of Digital Health Interviews and today's guest is Amir Lahav. In this interview, we dive into the rapidly changing world of healthcare technology focusing on the pharmaceutical industry.Amir, a…
Continue Reading
Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), have developed an artificial intelligence tool that predicts whether a patient will respond to cancer treatment drugs using individual…
Continue Reading
Accurate prediction of recurrence and progression in non-muscle invasive bladder cancer (NMIBC) is essential to inform management and eligibility for clinical trials. Despite substantial interest in developing artificial intelligence (AI) applications in NMIBC, their…
Continue Reading
Synapticure, a telemedicine company focused on neurodegenerative disease, announced it is partnering with the ALS Association to offer Synapticure’s telehealth platform as a supplement to in-person care at ALS Certified Treatment Centers of Excellence…
Continue Reading
What You Should Know:
– COTA, a leading real-world data (RWD) and analytics company in oncology, has announced a new collaboration with Sanofi.
– The strategic partnership aims to leverage RWD and artificial intelligence (AI) to…
Continue Reading
What You Should Know:
– Flatiron Health, a provider of real-world data (RWD) for cancer care, and the National Comprehensive Cancer Network® (NCCN®), an alliance of top cancer centers, have announced a renewal of their…
Continue Reading
What You Should Know:
myTomorrows, a global health technology company connecting patients with all possible treatment options, today announced a new partnership with brainstrust, a UK-based charity that helps people living with a brain tumor…
Continue Reading
What You Should Know:
– Nucleai, a pioneer in spatial AI biomarkers raises $14M in funding led by M Ventures, the corporate venture arm of Merck KGaA.
– The investment brings Nucleai’s total funding to $60M…
Continue Reading
